-
2023-506112-40-00
5
2018-09-26
R/R Multiple Myeloma
-
2023-506861-76-00
5
2018-08-09
Completely resected, Stage Ib (tumors ≥ 4 cm) to Stage IIIa, Anaplasti
-
2024-515755-37-00
4
2018-07-31
Limited disease small-cell lung cancer
-
2023-508551-40-00
6
2018-06-08
Coronary artery multi-vessel disease and left main stenosis
-
2023-504802-12-00
7
2018-05-16
Lymphoma of B-cell origin
-
2023-505222-34-00
7
2018-04-23
Relapsed/refractory (r/r) B-cell Non-Hodgkin’s Lymphoma (NHL)
-
2023-506110-43-00
9
2018-01-25
Multiple Myeloma
-
2024-514417-34-00
5
2017-12-14
Cancer
-
2024-514275-18-00
10
2017-12-06
Mantle Cell Lymphoma (MCL)
-
2023-506399-28-00
5
2017-11-08
Crohn's Disease
-
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
-
2023-505509-18-00
5
2017-07-12
mature aggressive B-cell lymphoma and leukemia in children and adolesc
-
2022-501763-40-00
5
2016-12-13
Pre-Exposure Prophylaxis of HIV-1 Infection
-
2024-517748-76-00
9
2016-11-14
Rectum cancer
-
2024-516178-31-00
5
2016-08-24
Head and neck squamous cell carcinoma (HNSCC)
-
2022-501253-37-00
4
2016-02-02
(A) Anal Squamous Cell Carcinoma,
(B) Biliary Adenocarcinoma (gallblad
-
2023-508683-30-00
5
2008-03-14
9vHPV vaccine is indicated in females ≥ 9 years of age in the prevent
-
2024-519278-37-00
4
2025-10-22
Lupus Nephritis
-
2025-521243-20-00
4
2025-10-23
Acromegaly
-
2024-513765-40-00
4
2025-03-27
Kidney transplant recipients
-
2024-514228-18-00
4
2025-01-16
Asthma in adults who remain uncontrolled despite medium to high dose I
-
2024-515236-69-00
11
2024-12-13
Acute coronary syndromes
-
2024-514111-10-00
6
2024-12-06
Heart failure with reduced ejection fraction (HFrEF)
-
2023-504964-41-00
7
2024-11-06
Idiopathic pulmonary fibrosis